They're powerful, but they're also fragile
Regarding FDA approval: because this is a compounded product, it is not directly FDA-approved
Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial

Key Research Areas Extracellular matrix remodelling GHK-Cu is extensively referenced in studies on collagen, elastin, and glycosaminoglycan synthesis in laboratory tissue models Wound healing mechanisms Investigated in controlled studies for its role in fibroblast activation, keratinocyte migration, and angiogenesis signalling Anti-inflammatory pathways Studied for inhibition of NF-B signalling and reduction of pro-inflammatory cytokine expression in cell culture Antioxidant activity Research has examined its capacity to upregulate superoxide dismutase and other endogenous antioxidant enzymes Nerve and tissue regeneration Referenced in studies exploring nerve growth factor (NGF) expression and axonal regeneration in vitro Hair follicle biology Investigated for effects on dermal papilla cell proliferation and follicle stimulation in skin research models Gene expression modulation Genome-wide studies have identified GHK-Cu as a potential modulator of over 4,000 human genes associated with tissue repair and inflammatory response Product Specifications About the Compound GHK-Cu is a tripeptide (Gly-His-Lys) with a high affinity for copper ions (Cu), forming a stable complex that has demonstrated significant biological activity across hundreds of peer-reviewed studies

It details the peptides role in stimulating blood vessel and nerve outgrowth, increasing the synthesis of collagen, elastin, and glycosaminoglycans, and supporting dermal fibroblast function